PLA2G7 and diabetes mellitus: Since this relationship appears to be independent of traditional risk factors and, specifically, independent of baseline LDLc levels, these data are consistent with the hypothesis that systemic inhibition of Lp-PLA2 activity may be a good therapeutic target in the prevention of this complication of diabetes.